You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Antonios Bayas1, Martina Menacher2, Martin Schwaiblmair3
1Neurology and Clinical Neurophysiology, University Hospital of Augsburg, Stenglinstrasse 2, 86156, Augsburg, Germany. antonios.bayas@uk-augsburg.de.
Alemtuzumab treatment for Multiple Sclerosis (MS) can rarely cause diffuse alveolar damage (DAD), a serious lung condition. This case report details a patient who recovered after developing DAD post-alemtuzumab.
Area of Science:
Background: